obesity-995x60.png obesity-995x60.png

FEATURED ARTICLES

Antibiotic resistance of bacteria-GettyImages-2195700743 The Rise Of Antimicrobial Resistance And Strategic Research Imperatives For 2026

Antimicrobial resistance (AMR) has increasingly worried public health officials and researchers alike in 2025. Now, in 2026, TAXI Pharmaceutical President and CEO Gregory C. Mario, MBA, is calling for more targeted approaches and the integration of AI for quicker discovery and development.

WHITE PAPERS AND CASE STUDIES

SERVICES AND PRODUCTS

Built From The Ground Up

Block Clinical understood from the beginning that intuitive technology that integrates openly with other systems and suppliers is the key to a streamlined, affordable solution.

Give us the opportunity to compete with your current set-up. We love a good challenge.

Block Clinical provides a single point of contact for Patients and Sites who support them throughout their journey, from start to finish.

With integrations at the heart of our efficiency model, Block Clinical automates payments in three areas: Site Payments, Patient Payments, and Supplier Payments.

At Endpoint Clinical, our solutions proactively problem-solve. We expect the unexpected, so you can focus on reaching key clinical trial milestones.

Your trusted RTSM solution, PULSE is designed to support all study designs with configurable, pre-validated components. PULSE empowers study teams to easily manage randomization and trial supply workflows with flexibility and precision.

NEWS